Unter dieser Rubrik wird jeden Monat eine Frage zu den verschiedenen Aspekten der IBD gestellt.
Machen Sie mit und überprüfen Sie Ihr Wissen! Die Auflösung wird unmittelbar geliefert!

Bei Problemen, sowie Anregungen und Beanstandungen verwenden Sie das Kontaktformular.

Questionnaire:
Infliximab, a monoclonal anti-TNFalpha antibody:   Which of the following answers are correct?
1.	Consists of a murine antihuman TNF monoclonal antibody attached to a human IgG1, therefore being approximately 5% mouse and 95% human. please choose... true false
2.	It has been shown that after administration of Infliximab (5mg/kg) at 0.2 and 6 weeks a reduction of draining fistula could be acchieved in 68% (placebo 26%) and closure of all fistula in 55% (placebo 13%). please choose... true false
3.	Common side effects include skin irritation, headache, upper respiratory tract infections and unspecific gastrointestinal symptoms. The main concern, however are the developement of HACA's (human antichimeric antibodies). please choose... true false
4.	Infliximab has a long half life (approx 9.5 days) and can be detected in serum up to 8 weeks. please choose... true false
5.	In an individual with active symptomatic Crohn's disease who requires corticosteroids and still has active disease, the use of infliximab is appropriate to initiate concomitantly with an immunosuppressant (such as azathioprine). please choose... true false

 med.info

 
 

 Alle Quiz

 Aktuelles Quiz

 Zurück